NCT06756763Completed
Head and Neck Quality of Life
Quality of Life After Head and Neck Free Flap Reconstruction: a Prospective Time to Deterioration Analysis
Source: ClinicalTrials.gov · Last updated 3 Jan 2025
Brief summary (registry, in English)
This study examines the quality of life for patients after head and neck free flap reconstruction, both pre-operative and at least 1 year post-operative. It aims to find out what influences quality of life, and whether these changes are stable over time. It will use a new method of analysis called "Time to Deterioration" which tells us when a patient notices a significant change in their quality of life, when subsequently does not get better.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 315 (actual)
- First submitted
- 27 Dec 2024
- Start date
- Mar 2015
- Primary completion date
- Sept 2023
- Lead sponsor
- Chang Gung Memorial Hospital
- Diseases
- Head and neck cancer, Childhood cancers
- NCT number
- NCT06756763
What you commit to
- Study type: Observational
- Participants enrolled: 315
- From Mar 2015 to the primary completion date, Sept 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- extra-oral disease eg scalp
Other
- did not undergo free flap reconstruction
- patients unable to consent
Who the study is looking for
- free flap reconstruction
- benign or malignant head and neck disease
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Chang Gung Memorial Hospital Coordinator of this site? Confirm its status | Linkou District | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.